Current status and future directions of nanovaccine for cancer: a bibliometric analysis during 2004-2023.

ABSTRACT:

Background

Nanovaccine treatment is an exciting area of research in immunology and personalized medicine, holding great promise for enhancing immune responses and targeting specific diseases. Their small size allows efficient uptake by immune cells, leading to robust immune activation. They can incorporate immune-stimulating molecules to boost vaccine efficacy. Therefore, nanovaccine can be personalized to target tumor-specific antigens, activating the immune system against cancer cells. Currently, there have been ample evidence showing the effectiveness and potential of nanovaccine as a treatment for cancer. However, there was rare bibliometric analysis of nanovaccine for cancer. Here we performed a bibliometric and visual analysis of published studies related to nanovaccine treat

SUBMITTER: Hou Y 

PROVIDER: S-EPMC11317272 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature